Literature DB >> 26771676

Changes in Total Lesion Glycolysis Evaluated by Repeated F-18 FDG PET/CT as Prognostic Factor in Locally Advanced Esophageal Cancer Patients Treated with Preoperative Chemoradiotherapy.

Samuel Chang1, Phillip J Koo, Jennifer J Kwak, Seong-Jang Kim.   

Abstract

AIMS: The present study was aimed to investigate whether volumetric parameters measured by sequential F-18 fluoro-D-glucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) could be used as prognostic factors in patients with locally advanced esophageal cancer (LAEC) who received preoperative chemoradiotherapy (CRT).
METHODS: A total of 61 patients with LAEC were included in the current study. All patients were evaluated by F-18 FDG PET/CT before and after 46 Gy of radiotherapy with a concurrent cisplatin-based chemotherapy. Initial, second, and percent changes (Δ, %) of semiquantitative and volumetric parameters were used to calculate recurrence-free survival (RFS) and overall survival (OS). The median values of each parameter were used as cutoff values. The prognostic significance was assessed using univariate and multivariate Cox proportional hazard regression analyses.
RESULTS: Cox proportional hazard regression analyses revealed that change in total lesion glycolysis (ΔTLG) was a potent predictor of RFS and OS. Kaplan-Meier survival curves showed better prognosis in higher ΔTLG.
CONCLUSION: Our data suggest that ΔTLG measured by sequential F-18 FDG PET/CT after preoperative CRT could provide prognostic information in LAEC patients.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26771676     DOI: 10.1159/000443018

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  5 in total

1.  18F-fluorodeoxyglucose positron emission computed tomography for monitoring tumor response in esophageal carcinoma treated with concurrent chemoradiotherapy.

Authors:  Peiliang Zhang; Zengyun Li; Dongqing Wang; Fuling Ma; Ran Zhang; Wanhua Liang; Mingping Sun; Zheng Fu; Xiaorong Sun
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

2.  PET Imaging and Rate of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma.

Authors:  M Hart Squires; Nicole Gower; Jennifer H Benbow; Erin E Donahue; Casey E Bohl; Roshan S Prabhu; Joshua S Hill; Jonathan C Salo
Journal:  Ann Surg Oncol       Date:  2021-10-09       Impact factor: 5.344

3.  GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.

Authors:  Yung-Kuan Tsou; Kung-Hao Liang; Wey-Ran Lin; Hsien-Kun Chang; Chen-Kan Tseng; Chau-Ting Yeh
Journal:  Oncotarget       Date:  2017-04-25

4.  Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET.

Authors:  Guobing Liu; Yan Hu; Xi Cheng; Yan Wang; Yushen Gu; Tianshu Liu; Hongcheng Shi
Journal:  BMC Cancer       Date:  2019-08-08       Impact factor: 4.430

5.  Prediction of the effects of radiation therapy in esophageal cancer using diffusion and perfusion MRI.

Authors:  Peiliang Wang; Xin Wang; Liang Xu; Jinming Yu; Feifei Teng
Journal:  Cancer Sci       Date:  2021-10-20       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.